Here are three things to know.
1. The drug is an anti-viral used for the prevention and treatment of influenza virus infection.
2. The treatment represents a generic version of Genentech’s Tamiflu.
2. Nesher, a subsidiary of Zydus Phramaceuticals USA, will produce the drug at a manufacturing facility in St. Louis.
More articles on supply chain:
Sanofi, Lonza to build $285M biologics facility
4 statistics on 2017 pharma price hikes
Lupin CEO: Border tax would significantly disrupt generic drugmakers’ supply chains
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
